Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial

NCT05308979 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT05308979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05308979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial
Lead sponsor
University of California, Irvine
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2022
Completion date
March 31, 2024
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, overactive bladder syndrome, urge incontinence, urinary frequency, urinary incontinence, urge, urinary urge incontinence, urinary urgency